✦ LIBER ✦

34 Phase II study of LY231514 in patients with advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Clarke, S.; Boyer, M.; Millward, M.; Findlay, M.; Ackland, S.; Childs, A.; Brew, S.; Walcher, V.; Watt, D.; Thornton, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of the multi-targeted ant

✍ Rusthoven, J.; Eisenhauer, E.; Butts, C.; Gregg, R.; Dancey, J.; Fisher, B.; Igl 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Phase II trial of mta (LY231514) in pati

✍ P. Postmus; K. Mattson; von Pawel; C. Manegold; E. Smit; M. Millward; S. Clarke; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 183 KB

A phase II study of low dose vinorelbine

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 134 KB

MTA (LY231514): a phase II trial in pati

✍ von Pawel, J.; Manegold, C.; Mattson, K.; Postmus, P.E.; Smit, E.F.; Clarke, S.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Results of a phase II study with vinorel

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Phase II study of oxaliplatin (L-OHP) in

✍ Monnet, I.; Brienza, S.; Voisin, S.; Gastiaburu, J.; Armand, J.P.; Cvitkovic, E. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 170 KB